Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial

Develop and validate a strategy to improve HIV testing rates using HIV teams. A prospective clinical trial was conducted from January 2020 to July 2023 in two Dutch university hospitals. The intervention involved implementing HIV teams to provide peer awareness, education, and feedback to physicians...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) Jg. 39; H. 8; S. 995
Hauptverfasser: Jordans, Carlijn C E, Vliegenthart-Jongbloed, Klaske, Osbak, Kara K, Hanssen, Jaap L J, van Beek, Jan, Vriesde, Marion, van Holten, Natasja, Dorama, Willemien, van der Sluis, Dorien, de Steenwinkel, Jurriaan, van Kampen, Jeroen, Verbon, Annelies, Roukens, Anna H E, Rokx, Casper
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England 01.07.2025
Schlagworte:
Adolescent
Adult
Aged
Female
HIV Infections - diagnosis
HIV Infections - epidemiology
HIV Testing - statistics & numerical data
Hospitals
Hospitals, University
Humans
Male
Mass Screening - statistics & numerical data
Middle Aged
Netherlands - epidemiology
Prospective Studies
Young Adult
Netherlands
HIV
sexually transmitted infections
HIV indicator condition
healthcare practitioner
HIV testing
HIV positivity rate
hospital
ISSN:1473-5571, 1473-5571
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Develop and validate a strategy to improve HIV testing rates using HIV teams. A prospective clinical trial was conducted from January 2020 to July 2023 in two Dutch university hospitals. The intervention involved implementing HIV teams to provide peer awareness, education, and feedback to physicians treating patients ≥18 years newly diagnosed with HIV indicator conditions. The primary outcome was the HIV testing rate. Secondary outcomes included testing rates by specialty, HIV prevalence, and reasons for withholding testing. Of the 313 666 newly registered diagnoses, 2395 involved indicator conditions. The overall HIV testing rate of newly diagnosed HIV indicator conditions increased from 50.1% (222/443) preimplementation to 80.7% (1575/1952) postimplementation of HIV teams ( P  < 0.001) with sustained improvement during the observation period (range 72.4-90.4%). The intervention was effective across physicians from all medical specialties. HIV prevalence among those tested was 0.6% [95% confidence interval (CI) 0.3-1.1]. Peer feedback for 411 untested indicator conditions, resulted in 69 (16.3%) additional HIV tests. Failure to test frequently remained without reason (50.6%) or due to patient loss of follow-up (18.4%). Multivariate analysis indicated that women with indicator conditions were tested less often [adjusted odds ratio (aOR) 0.59, 95% CI 0.45-0.79, P  < 0.01], and indicator conditions without HIV testing recommendations in national guidelines were also less likely to be tested for HIV (aOR 0.36, 95% CI 0.27-0.48, P  < 0.01). For external validation, we implemented this intervention in a second hospital, where it also significantly increased the testing rate postimplementation of HIV teams. Implementing HIV teams in hospitals is feasible, effective and leads to a sustained increase in HIV indicator condition-guided testing, supporting its broader adoption.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1473-5571
1473-5571
DOI:10.1097/QAD.0000000000004167